Management of Pediatric Strokes With Alteplase (Tissue Plasminogen Activator)
نویسندگان
چکیده
In the pediatric population, ischemic stroke is rare. Pediatric patients with acute are eligible for intravenous thrombolysis and/or mechanical thrombectomy. However, due to rare occurrence of strokes and national shortage neurologists, timely diagnosis appropriate treatment can be challenging. We report a case 16-year-old female who presented an our adult comprehensive program.
منابع مشابه
Administering Intravenous Alteplase (Tissue Plasminogen Activator [tPA])
Step 1: Eligibility-The eligibility criteria for patients with acute ischemic stroke within 3 hours of symptom onset include: • An adult (> 18 years of age) • Exclusion of intrancranial hemorrhage by an imaging technique sensitive for the presence of hemorrhage • Arrives at the emergency department in time to be treated within 3 hours of symptom onset • The recommended dose of IV tPA is 0.9 mg/...
متن کاملRecombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke
THE FOOD AND DRUG ADMINIStration (FDA) approval in June 1996 of intravenous recombinant tissue-type plasminogen activator (rt-PA) for patients with acute ischemic stroke treated within 3 hours of symptom onset marked a historic first step in treating this devastating disease. This approval was primarily based on the results of the National Institute of Neurologic Disorders (NINDS) trials (1 and...
متن کاملThe Outcome of Treatment With Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
Background: Thrombolytic therapy is the recommended treatment of acute ischemic stroke. It is crucial to evaluate the treatment results with recombinant Tissue Plasminogen Activator (r-TPA) in patients with acute stroke. Objectives: This study aimed to evaluate treatment outcomes with r-TPA in patients with acute stroke in a referral stroke center in Iran. Materials & Methods: In this retrosp...
متن کاملLingual haematoma after treatment with alteplase (recombinant tissue plasminogen activator) for acute myocardial infarction.
A 69 year old previously healthy man was admitted with a 40 minute history of chest pain. The electrocardiograph showed evidence of an acute anterolateral myocardial infarction (MI). He was treated with soluble aspirin (300 mg), heparin (5000 units bolus), alteplase (rtPA) (100 mg), and heparin infusion (1000 units/h). An hour and 50 minutes later he complained of a dry mouth and examination sh...
متن کاملVentricular arrhythmias during treatment with alteplase (recombinant tissue plasminogen activator) in suspected acute myocardial infarction.
Continuous electrocardiography during the first 24 hours of a stay in a coronary care unit was used to record ventricular arrhythmias during treatment with alteplase (recombinant tissue plasminogen activator) or placebo. Recordings were made on 378 of the 436 patients admitted to a double blind trial of alteplase or placebo in one participating centre of the Anglo-Scandinavian study of early th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cureus
سال: 2021
ISSN: ['2168-8184']
DOI: https://doi.org/10.7759/cureus.17088